Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Epidural Electrical Stimulation to Support Hemodynamic Management in Individuals With Parkinson's Disease

NCT: NCT06920134 · RECRUITING

NCT IDNCT06920134
StatusRECRUITING
Start Date2025-07-03
Completion2031-05-01
SponsorEcole Polytechnique Fédérale de Lausanne (OTHER)
First posted
Last updated

Brief Summary

The PD-HemON study aims to evaluate the safety and preliminary efficacy of ARC-IM Therapy (Epidural Electrical Stimulation) to support hemodynamic management in people with typical and atypical Parkinson's Disease, who suffer from orthostatic hypotension.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑